Teladoc price target raised to $11 from $10 at Cantor Fitzgerald

Cantor Fitzgerald raised the firm’s price target on Teladoc (TDOC) to $11 from $10 and keeps an Overweight rating on the shares. The firm expects the stock will see some relief following the soft 2025 guidance, saying in a research note that the overhang on the stock was largely due to the lack of investor confidence and management commentary in the direction of both the Integrated Care and BetterHelp segments. Cantor says the 2025 guidance is encouraging to weak sentiment.